<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Biol Chem</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Biol. Chem</journal-id>
<journal-id journal-id-type="hwp">jbc</journal-id>
<journal-id journal-id-type="pmc">jbc</journal-id>
<journal-id journal-id-type="publisher-id">JBC</journal-id>
<journal-title-group>
<journal-title>The Journal of Biological Chemistry</journal-title>
</journal-title-group>
<issn pub-type="ppub">0021-9258</issn>
<issn pub-type="epub">1083-351X</issn>
<publisher>
<publisher-name>American Society for Biochemistry and Molecular Biology</publisher-name>
<publisher-loc>11200 Rockville Pike, Suite 302, Rockville, MD 20852-3110, U.S.A.</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28389566</article-id>
<article-id pub-id-type="pmc">5448084</article-id>
<article-id pub-id-type="publisher-id">R116.752899</article-id>
<article-id pub-id-type="doi">10.1074/jbc.R116.752899</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Minireviews</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Microbial metabolites in health and disease: Navigating the unknown in search of function</article-title>
<alt-title alt-title-type="short">MINIREVIEW: Microbial metabolites in health and disease</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Martinez</surname>
<given-names>Kristina B.</given-names>
</name>
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Leone</surname>
<given-names>Vanessa</given-names>
</name>
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chang</surname>
<given-names>Eugene B.</given-names>
</name>
<xref ref-type="aff" rid="aff1"></xref>
<xref ref-type="corresp" rid="cor1">
<sup>1</sup>
</xref>
</contrib>
<aff id="aff1">From the Department of Medicine, Knapp Center for Biomedical Discovery, University of Chicago, Chicago, Illinois 60637</aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>1</label> To whom correspondence should be addressed: <addr-line>900 E. 57th St., Dept. of Medicine, University of Chicago, Chicago, IL 60637.</addr-line> Tel.: <phone>773-702-6458</phone>; Fax: <fax>773-702-2281</fax>; E-mail: <email>echang@medicine.bsd.uchicago.edu</email>.</corresp>
<fn fn-type="edited-by">
<p>Edited by Ruma Banerjee</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>26</day>
<month>5</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>7</day>
<month>4</month>
<year>2017</year>
</pub-date>
<volume>292</volume>
<issue>21</issue>
<fpage>8553</fpage>
<lpage>8559</lpage>
<permissions>
<copyright-statement>Â© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>The American Society for Biochemistry and Molecular Biology, Inc.</copyright-holder>
</permissions>
<self-uri content-type="pdf" xlink:href="zbc02117008553.pdf"></self-uri>
<abstract>
<p>The gut microbiota has been implicated in the development of a number of chronic gastrointestinal and systemic diseases. These include inflammatory bowel diseases, irritable bowel syndrome, and metabolic (<italic>i.e.</italic> obesity, non-alcoholic fatty liver disease, and diabetes) and neurological diseases. The advanced understanding of host-microbe interactions has largely been due to new technologies such as 16S rRNA sequencing to identify previously unknown microbial communities and, more importantly, their functional characteristics through metagenomic sequencing and other multi-omic technologies, such as metatranscriptomics, metaproteomics, and metabolomics. Given the vast array of newly acquired knowledge in the field and technological advances, it is expected that mechanisms underlying several disease states involving the interactions between microbes, their metabolites, and the host will be discovered. The identification of these mechanisms will allow for the development of more precise therapies to prevent or manage chronic disease. This review discusses the functional characterization of the microbiome, highlighting the advances in identifying bioactive microbial metabolites that have been directly linked to gastrointestinal and peripheral diseases.</p>
</abstract>
<kwd-group>
<kwd>cardiovascular disease</kwd>
<kwd>inflammatory bowel disease (IBD)</kwd>
<kwd>metabolomics</kwd>
<kwd>metagenomics</kwd>
<kwd>neurological disease</kwd>
<kwd>meta-omics</kwd>
<kwd>metatranscriptomics</kwd>
<kwd>microbial metabolites</kwd>
<kwd>multi-omics</kwd>
</kwd-group>
<funding-group>
<award-group id="award1">
<funding-source>
<institution-wrap>
<institution>National Institute of Diabetes and Digestive and Kidney Diseases
</institution>
<institution-id institution-id-type="open-funder-registry">10.13039/100000062</institution-id>
</institution-wrap>
</funding-source>
<award-id>DK042086</award-id>
<award-id>DK097268</award-id>
<award-id>DK102872</award-id>
</award-group>
</funding-group>
</article-meta>
</front>
</article>
</pmc-articleset>